KUKJEON PHARMACEUTICAL Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,715	10,992	21,546	19,099
Short-Term Investments	20,000	15,000	45,000	20,160
Trading Asset Securities	46,613	38,840	28,425	-
Cash & Short-Term Investments	71,328	64,833	94,971	39,259
Cash Growth	25.19%	-31.73%	141.91%	-
Accounts Receivable	29,140	26,850	21,923	20,015
Other Receivables	475.44	1,964	867.93	194.62
Receivables	29,956	29,065	23,403	20,409
Inventory	24,149	27,563	20,209	16,207
Prepaid Expenses	437.79	494.91	246.48	143.8
Other Current Assets	1,623	2,036	4,064	896.09
Total Current Assets	127,493	123,992	142,893	76,915
Property, Plant & Equipment	88,240	86,060	46,118	24,026
Long-Term Investments	4,399	4,364	3,173	3,493
Goodwill	420.39	420.39	420.39	-
Other Intangible Assets	910.77	971	903.51	422.37
Long-Term Deferred Tax Assets	2,020	1,964	-	794.9
Other Long-Term Assets	7,247	7,090	2,379	517.79
Total Assets	234,500	225,102	196,097	106,989
Accounts Payable	14,806	11,693	9,474	10,989
Accrued Expenses	376.78	289.73	178.99	83.02
Short-Term Debt	49,231	15,224	7,883	5,133
Current Portion of Long-Term Debt	2,853	36,802	26,015	1,457
Current Portion of Leases	267.79	236.17	147.15	124.88
Current Income Taxes Payable	407.9	-	-	1,057
Current Unearned Revenue	8.79	35.16	-	-
Other Current Liabilities	41,126	35,542	26,993	3,007
Total Current Liabilities	109,078	99,823	70,691	21,852
Long-Term Debt	24,241	26,183	25,091	942.84
Long-Term Leases	413	334.14	202.84	193.97
Long-Term Deferred Tax Liabilities	-	10.45	1,365	-
Other Long-Term Liabilities	1,223	1,296	6,425	849.76
Total Liabilities	134,955	127,646	103,774	23,838
Common Stock	4,907	4,907	4,907	4,907
Additional Paid-In Capital	62,139	62,386	62,386	62,397
Retained Earnings	32,100	29,129	24,305	15,848
Treasury Stock	-1.16	-1.16	-1.16	-1.16
Comprehensive Income & Other	0	0	0	0
Total Common Equity	99,145	96,422	91,597	83,150
Minority Interest	400.65	1,035	725.74	-
Shareholders' Equity	99,545	97,456	92,323	83,150
Total Liabilities & Equity	234,500	225,102	196,097	106,989
Total Debt	77,006	78,780	59,339	7,852
Net Cash (Debt)	-5,678	-13,947	35,632	31,407
Net Cash Growth	-	-	13.45%	-
Net Cash Per Share	-115.71	-284.24	695.44	712.02
Filing Date Shares Outstanding	49.07	49.07	49.07	49.07
Total Common Shares Outstanding	49.07	49.07	49.07	49.07
Working Capital	18,415	24,169	72,202	55,063
Book Value Per Share	2020.51	1965.01	1866.70	1694.56
Tangible Book Value	97,814	95,030	90,274	82,728
Tangible Book Value Per Share	1993.38	1936.66	1839.72	1685.95
Land	20,224	19,837	15,613	3,997
Buildings	37,369	36,673	11,300	8,252
Machinery	30,075	22,297	11,051	7,554
Construction In Progress	718.79	6,407	13,388	9,214

Source: S&P Capital IQ. Standard template. Financial Sources.